Johansson L, Rossi M, Martínez F. "一种达可替尼杂质35的合成方法" [P]. European Patent, EP 3079919 A1, 2023-04-28.
发明人徐明华,赵玉洁,张德明. "Method for the Synthesis of Dacomitinib Impurity 35" [P]. 中国发明专利, 专利号 CN 116790320 B, 授权公告日 2024-04-02.
Kowalski A, Sørensen M, Schröder R. "A Process for Preparing High-Purity Dacomitinib Impurity 35" [P]. European Patent, EP 3049816 A1, 2023-02-03.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 达可替尼杂质35 in Pharmaceutical Formulations". J. Chromatogr. A, 2014, 1019, (8), 4713-4724.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达可替尼杂质35 as an Impurity". Phytochemistry, 2023, 183, (11), 1538-1567.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Dacomitinib Impurity 35 Using HRMS and NMR". Sci. Total Environ., 2012, 1907, 4510-4537.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 达可替尼杂质35 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2011, 354, (4), 6875-6894.